Rolando Nortilli

Ki-67 immunostaining in 322 primary breast cancers: Associations with clinical and pathological variables and prognosis

Annamaria Molino, Rocco Micciolo, Monica Turazza et al. · International Journal of Cancer · 1997 · 124 citations

Medicine, Oncology, Pathology +15

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

Rolando Nortilli, Savina Aversa, Adriano Paccagnella et al. · Melanoma Research · 2001 · 83 citations

Medicine, Oncology, Pharmacology +11

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting

Luisa Carbognin, Sara Pilotto, Rolando Nortilli et al. · The Oncologist · 2016 · 71 citations · Full text

Medicine, Immunology, Oncology +17

Cisplatin, Dacarbazine With or Without Subcutaneous Interleukin-2, and Interferon Alfa-2b in Advanced Melanoma Outpatients: Results From an Italian Multicenter Phase III Randomized Clinical Trial

Ruggero Ridolfi, Vanna Chiarion‐Sileni, Michele Guida et al. · Journal of Clinical Oncology · 2002 · 71 citations

Medicine, Oncology, Pharmacology +17

Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis

Annamaria Molino, Giuseppe Pelosi, Monica Turazza et al. · Breast Cancer Research and Treatment · 1997 · 68 citations

Medicine, Oncology, Pathology +16